Top roles from Star this month include Senior Product Manager, Anaemia Business Manager, Compliance Manager, Medical Manager, Medical Projects and NHS Collaboration Partner, and Social Media Director positions covering a range of territories. Read more -
The MHRA consults on how best to engage with patients and the public, the world’s first full colour 3D printing technology is used in kidney cancer surgery, and the MD of Roche Diabetes Care says it’s time for the industry to work with health systems to speed up innovation access.
Here at Star we’re working hard to recruit top talent for our clients and place fantastic people in roles they’ll love. If these longer evenings have got you thinking about changing roles, or you’re just curious about what’s out there, take a look at our top roles for August.
Star is delighted to announce that they have retained their Gold standard Investors In People accreditation. Investors In People (IIP), work with organisations globally who want to put the time and focus into their employees to develop them and help them reach their full potential.
We grabbed some time with Star Account Delivery Manager, Dan Everitt, to talk assessment centres, and just what it is that makes them so valuable for both candidates and clients.
Star is very proud to have been recognised by Great Place to Work® as one of the UK’s Best Workplaces for Women, including for equal numbers of men and women in teams, a flexible working policy, and more.
A market-leading outsourcing and resourcing provider that delivers award-winning quality services, Star are delighted to announce a new chapter in their journey, unveiling a new brand look that highlights their unrivalled offering to the healthcare industry.
Many of us recognise intellectually that we need others’ knowledge to address the opportunities and challenges we face in our day to day jobs in pharma, yet we still lack the time or motivation to collaborate. Engaging with third parties all too often feels inefficient.
Our world is changing. Over the last 15 years, 52% of Fortune 500 companies have disappeared. I often wonder if this trend will impact our sector. While pharma has been relatively isolated from disruptive technologies, the recently intensified pressure on drug pricing from policy makers is really challenging pharma executives.
As technology continues to evolve, different ways to communicate are endless; telephone, email, Skype and social media are integral to work life today.